CAS: 133099-04-4 - Darifenacin

Formel: C₂₈H₃₀N₂O₂

InChl: InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1

InChI Key: InChIKey=HXGBXQDTNZMWGS-RUZDIDTESA-N

SMILES: O=C(N)C(C=1C=CC=CC1)(C=2C=CC=CC2)C3CN(CCC4=CC=C5OCCC5=C4)CC3

Synonyme:

• (3S)-(1-Carbamoyl-1,1-diphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine
• (3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide
• (3S)-3-(2-Amino-2-oxo-1,1-diphenylethyl)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-1-pyrrolidine
• (S)-(-)-3-(1-Carbamoyl-1,1-diphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine
• (S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide
• (S)-2-[1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenylacetamide
• 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide
• 2-{1-[2-(2,3-Dihydro-1-Benzofuran-5-Yl)Ethyl]Pyrrolidin-3-Yl}-2,2-Diphenylacetamide
• 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, (3S)-
• 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, (S)-
• Darifenacin intermediate
• Uk 88525
• Vesigard

rac-Darifenacin-d4

CAS: 1189701-43-6 133099-04-4

• Formel: C₂₈H₂₆D₄N₂O₂
• Farbe und Form: White To Off-White Solid
• Molekulargewicht: 430.58

Darifenacin

CAS: 133099-04-4

• Formel: C₂₈H₃₀N₂O₂
• Farbe und Form: White To Off-White Solid
• Molekulargewicht: 426.56

Darifenacin

CAS: 133099-04-4

• Formel: C₂₈H₃₀N₂O₂
• Molekulargewicht: 426.55

Darifenacin

CAS: 133099-04-4

Darifenacin is an antispasmodic drug that inhibits p-glycoprotein (p-gp) and prevents the reuptake of neurotransmitters, …

• Formel: C₂₈H₃₀N₂O₂
• Reinheit: Min. 95%
• Molekulargewicht: 426.55 g/mol